{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T13:18:22Z","timestamp":1779196702934,"version":"3.51.4"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1,30]]},"abstract":"<jats:sec>\n                    <jats:title>Rationale:<\/jats:title>\n                    <jats:p>Hereditary hemorrhagic telangiectasia (HHT) is a rare autosomal dominant vascular disorder characterized by recurrent epistaxis, mucocutaneous telangiectasias, and visceral arteriovenous malformations (AVMs), which can lead to serious bleeding and organ complications. Early diagnosis and multidisciplinary management are essential.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patient concerns:<\/jats:title>\n                    <jats:p>A 61-year-old man presented with intermittent melena, hematochezia, and severe epistaxis. While undergoing hemodialysis for newly diagnosed end-stage renal disease, he developed respiratory distress, hemoptysis, and hemorrhagic shock.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Diagnoses:<\/jats:title>\n                    <jats:p>Clinical suspicion of HHT was supported by imaging that revealed a pulmonary AVM. Genetic testing confirmed a heterozygous endoglin mutation, establishing a diagnosis of HHT type 1.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions:<\/jats:title>\n                    <jats:p>He underwent endoscopic hemostasis, tracheostomy, pulmonary AVM embolization, inhaled tranexamic acid, and thalidomide to control bleeding.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcomes:<\/jats:title>\n                    <jats:p>Thalidomide reduced the frequency of transfusions and the severity of bleeding; however, intermittent bleeding persisted. The patient remained ventilator-dependent due to respiratory compromise.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Lessons:<\/jats:title>\n                    <jats:p>HHT should be suspected in patients presenting with recurrent bleeding at multiple sites. Genetic testing is essential for confirming the diagnosis, while a combination of endoscopic, interventional, and antiangiogenic therapies plays a crucial role in management. Despite these treatments, controlling bleeding remains challenging, highlighting the importance of individualized, multidisciplinary care.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000047435","type":"journal-article","created":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T17:01:15Z","timestamp":1769965275000},"page":"e47435","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Hereditary hemorrhagic telangiectasia patient with pulmonary arteriovenous malformation: A case report"],"prefix":"10.1097","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-0158-2107","authenticated-orcid":false,"given":"Ching Wen","family":"Pang","sequence":"first","affiliation":[{"name":"Department of Nursing, National Taiwan University Hospital, Taipei City, Taiwan (R.O.C.)."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20260519","first-page":"e20230133","article-title":"Pulmonary arteriovenous malformations in Rendu\u2013Osler\u2013Weber syndrome.","volume":"23","author":"de Ara\u00fajo-Gomes","year":"2024","journal-title":"J Vasc Bras"},{"key":"R2-20260519","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/(SICI)1096-8628(20000306)91:1<66::AID-AJMG12>3.0.CO;2-P","article-title":"Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu\u2013Osler\u2013Weber syndrome).","volume":"91","author":"Shovlin","year":"2000","journal-title":"Am J Med Genet"},{"key":"R3-20260519","doi-asserted-by":"crossref","first-page":"4698","DOI":"10.3390\/jcm11164698","article-title":"Hereditary hemorrhagic telangiectasia: diagnosis and management.","volume":"11","author":"Cuesta","year":"2022","journal-title":"J Clin Med"},{"key":"R4-20260519","doi-asserted-by":"crossref","first-page":"e176379","DOI":"10.1172\/JCI176379","article-title":"Hereditary hemorrhagic telangiectasia: from signaling insights to therapeutic advances.","volume":"134","author":"Al Tabosh","year":"2024","journal-title":"J Clin Invest"},{"key":"R5-20260519","doi-asserted-by":"crossref","first-page":"5245","DOI":"10.3390\/jcm11175245","article-title":"Hereditary hemorrhagic telangiectasia: genetics, pathophysiology, diagnosis, and management.","volume":"11","author":"Viteri-No\u00ebl","year":"2022","journal-title":"J Clin Med"},{"key":"R6-20260519","doi-asserted-by":"crossref","first-page":"5404","DOI":"10.3390\/jcm13185404","article-title":"The role of thalidomide and its analogs in the treatment of hereditary hemorrhagic telangiectasia: a systematic review.","volume":"13","author":"Ugur","year":"2024","journal-title":"J Clin Med"},{"issue":"1_suppl","key":"R7-20260519","first-page":"S1","article-title":"Clinical practice guideline: nosebleed (Epistaxis).","volume":"162","author":"Tunkel","year":"2020","journal-title":"Otolaryngol Head Neck Surg"},{"key":"R8-20260519","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1002\/alr.22961","article-title":"Randomized, controlled, double-blinded clinical trial of effect of bevacizumab injection in management of epistaxis in hereditary hemorrhagic telangiectasia patients undergoing surgical cauterization.","volume":"12","author":"Khanwalkar","year":"2022","journal-title":"Int Forum Allergy Rhinol"},{"key":"R9-20260519","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.chest.2018.09.026","article-title":"Inhaled tranexamic acid for hemoptysis treatment: a randomized controlled trial.","volume":"154","author":"Wand","year":"2018","journal-title":"Chest"},{"key":"R10-20260519","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/j.chest.2022.11.021","article-title":"Nebulized vs IV tranexamic acid for hemoptysis: a pilot randomized controlled trial.","volume":"163","author":"Gopinath","year":"2023","journal-title":"Chest"},{"key":"R11-20260519","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0016-5107(00)70384-1","article-title":"Hemoclipping for postpolypectomy and postbiopsy colonic bleeding.","volume":"51","author":"Parra-Blanco","year":"2000","journal-title":"Gastrointest Endosc"},{"key":"R12-20260519","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S0016-5107(04)02221-7","article-title":"Argon plasma coagulation for prevention of recurrent bleeding from GI angiodysplasias.","volume":"60","author":"Olmos","year":"2004","journal-title":"Gastrointest Endosc"},{"key":"R13-20260519","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1017\/S0022215118001536","article-title":"The use of thalidomide therapy for refractory epistaxis in hereditary haemorrhagic telangiectasia: systematic review.","volume":"132","author":"Harrison","year":"2018","journal-title":"J Laryngol Otol"},{"key":"R14-20260519","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/nm.2131","article-title":"Thalidomide stimulates vessel maturation and reduces epistaxis in individuals with hereditary hemorrhagic telangiectasia.","volume":"16","author":"Lebrin","year":"2010","journal-title":"Nat Med"},{"key":"R15-20260519","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1182\/blood.V120.21.629.629","article-title":"Efficacy of thalidomide in the treatment of severe recurrent epistaxis in hereditary hemorrhagic telangiectasia (HHT): preliminary results of an ongoing study.","volume":"120","author":"Balduini","year":"2012","journal-title":"Blood"},{"key":"R16-20260519","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.3748\/wjg.v25.i21.2549","article-title":"Diagnostic and therapeutic challenges of gastrointestinal angiodysplasias: a critical review and view points.","volume":"25","author":"Garc\u00eda-Compe\u00e1n","year":"2019","journal-title":"World J Gastroenterol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000047435","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T13:03:11Z","timestamp":1779195791000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000047435"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,30]]},"references-count":16,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000047435","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,30]]},"assertion":[{"value":"2025-08-09","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-05","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}